Becton, Dickinson and Company (BDX) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to BD's fourth quarter and full year fiscal 2025 earnings call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com, or by phone at 800-839-2383 for domestic calls and area code plus 1-402-220-7000. 7202 for international calls. For today's call, all parties have been placed in a listen-only mode until the question and answer session. I will now turn the call over to Adam Reif, Vice President, Investor Relations. Good morning and welcome to BD's earnings call. I'm Adam Reif, Vice President of Investor Relations. Thank you for joining us. This call is being made available via audio webcast at BD.com. Earlier this morning, BD released its results for the fourth quarter and full year fiscal 2025. The press release and presentation can be accessed on the IR website at investors.bd.com. Leading today's call are Tom Poland, BD's Chairman, Chief Executive Officer and President, and Crystal Arifas, Executive Vice President and Chief Financial Officer. Before we get started, I want to remind you that we will be making forward-looking statements. You can read the disclaimer in our earnings release and the disclosures in our SEC filings on our investor relations website. Unless otherwise specified, all comparisons will be made on a year-on-year basis versus the relevant fiscal period. Revenue percentage changes are on an adjusted FX neutral basis unless otherwise noted. Beginning October 1st, we began operating under our previously disclosed new BD segment structure that includes medical essentials, connected care, biopharma systems, and interventional, and a fifth life sciences segment comprised of biosciences and diagnostic solutions. Reconciliations between gap and non-ga...